Defunct Company
Total Trials
9
As Lead Sponsor
1
As Collaborator
8
Total Enrollment
419
NCT03513939
A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation
Phase: Phase 1/2
Role: Collaborator
Start: Feb 7, 2019
Completion: Oct 31, 2028
NCT05777330
Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes
Phase: N/A
Start: Aug 9, 2023
Completion: Aug 31, 2028
NCT07084805
Diabetes Inspired Culinary Education (DICE): Culinary Medicine Intervention for At-Risk Youth With Type 1 Diabetes
Start: Sep 1, 2023
Completion: Dec 31, 2026
NCT05979844
MDMA-assisted Brief Cognitive Behavioral Conjoint Therapy for PTSD
Phase: Phase 3
Start: Oct 6, 2023
Completion: Sep 30, 2025
NCT06981234
Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial
Phase: Phase 2
Start: Aug 14, 2024
Completion: Jun 30, 2027
NCT05696366
Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes
Start: Sep 9, 2024
Completion: Jan 31, 2028
NCT06117306
MDMA-assisted Massed Prolonged Exposure for PTSD
Role: Lead Sponsor
Start: Oct 25, 2024
Completion: Jan 1, 2026
NCT06217302
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Start: Oct 31, 2024
Completion: May 31, 2029
NCT07155252
Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening
Start: Aug 26, 2025
Completion: Sep 30, 2027